Distinguish sodium concentration from sodium stores, interpret tonicity and urine responses, and connect changing physiology to safer correction decisions.
A sodium concentration is not a salt inventory. An edematous patient can have excess total body sodium and a low serum sodium, while a dehydrated patient can have lost sodium and still be hypernatremic. First ask what the concentration says about water relative to solute, then ask what the circulation and kidneys are doing.
Select and monitor an infusion regimen according to the clinical setting. Severe neurologic symptoms plausibly attributable to hypotonic hyponatremia require urgent monitored treatment by the responsible clinical team while the cause is investigated.
Which particles change cell water?
Osmolality counts dissolved particles per kilogram of water. Tonicity, or effective osmolality, describes the sustained osmotic effect of particles that do not readily equilibrate across the relevant cell membrane. Water moves toward the compartment with the higher effective osmole concentration. Sodium salts dominate extracellular tonicity; extracellular glucose becomes particularly important in marked hyperglycemia. A rapid fall in extracellular tonicity favors cell swelling; a rise favors cell shrinkage. European physiology and diagnostic guidance [1]
Urea contributes to measured osmolality but usually crosses cell membranes sufficiently readily that it does not sustain the same tonic water shift. Therefore a high blood urea nitrogen concentration can make measured osmolality look normal or high despite low tonicity. This is a usual steady-state distinction, not a claim that rapid urea gradients, such as during dialysis, never matter.
Two calculations, different questions
With sodium in mmol/L and glucose and BUN in mg/dL, calculated osmolality ≈ 2 × sodium + glucose/18 + BUN/2.8. The usual calculated estimate of effective osmolality ≈ 2 × sodium + glucose/18 excludes BUN. These clinical estimates are conventionally reported in mOsm/kg; they approximate a measurement rather than replacing an osmometer. Do not enter glucose in mmol/L into a formula that divides by 18. BUN is nitrogen concentration, not the mass concentration of urea. Calculated osmolality and units [10]Effective versus ineffective osmoles [1]
Worked example: sodium 124, glucose 90 and BUN 112 give calculated osmolality 248 + 5 + 40 = 293 mOsm/kg, but calculated effective osmolality is 253 mOsm/kg. If measured osmolality is 295, the measurement and total calculation are close, yet neither makes this plasma isotonic. Urea explains much of the difference. Typical measured serum osmolality is about 275-295 mOsm/kg; interpret the laboratory range and any unmeasured osmoles.
Now compare sodium 126 and glucose 900: calculated effective osmolality is 252 + 50 = 302 mOsm/kg. Glucose has drawn water out of cells, genuinely lowering sodium concentration in plasma water. This is translocational hyponatremia, not assay error. A glucose-corrected sodium estimates the concentration after glucose normalization under simplifying assumptions. Coefficients of 1.6 or 2.4 mmol/L per 100 mg/dL glucose above 100 give 138.8 or 145.2 mmol/L here. The coefficient varies with conditions and glucose range; concurrent urinary water and electrolyte losses make a single correction estimate insufficient for fluid decisions. Translocation versus artifact [1]Correction coefficients [4]
Pseudohyponatremia is different: marked lipids or proteins reduce the plasma water fraction and can bias an indirect ion-selective electrode assay that dilutes the specimen. Direct ISE measures an undiluted specimen and avoids this particular artifact. Isolated pseudohyponatremia does not cause a hypotonic cell-water shift. Mixed disease is possible, so check measured osmolality, glucose, assay method and clinical context rather than declaring every normal-osmolality low sodium harmless.
Predict: which cell shrinks, one exposed to additional extracellular glucose or one exposed to an equilibrated urea increase? Check: glucose sustains the extracellular gradient in this comparison; urea increases the total particle count without the same sustained shrinkage. Transfer: a high BUN cannot be added to tonicity to exclude hypotonic hyponatremia.
A concentration has a numerator and a denominator
Serum sodium reflects the relationship of exchangeable body sodium plus potassium to total body water, not simply sodium intake. This relationship is useful qualitatively even though real physiology includes nonexchangeable stores and other terms. At a fixed effective solute pool, retaining water lowers concentration and losing water raises it. Adding potassium can also increase serum sodium; tracking only infused sodium misses part of the correction. Body-water physiology [1]
For a deliberately simplified model, hold an exchangeable cation pool at 5,880 mmol and divide it by 42 L of total body water: the concentration index is 140 mmol/L. Retain 7 L without solute and the index becomes 120 mmol/L; lose 3 L from the starting state and it becomes approximately 150.8 mmol/L. These are closed-system comparisons, not patient predictions. In a patient, food, intravenous fluids, urine and gastrointestinal losses can change both sides of the ratio.
Extracellular volume and effective arterial blood volume answer different questions. Edema identifies interstitial fluid accumulation. Effective arterial volume describes the arterial filling available to perfuse organs. Heart failure can reduce effective forward flow despite congestion; cirrhosis can produce splanchnic vasodilation despite ascites. The kidney can respond to arterial underfilling by retaining sodium and water even when the patient already has too much of both. Disproportionate water retention lowers serum sodium. Expanded extracellular volume [1]Cirrhosis physiology [8]
Conversely, diarrhea may remove both sodium and water. A sodium of 154 does not prove sodium gain: water loss may be proportionally greater. A sodium of 122 does not rule out depletion: replacement with hypotonic fluid and volume-driven antidiuresis can retain water relative to remaining solute. Examination, fluid balance, weight trajectory, perfusion and renal function must accompany the concentration.
Predict: if water rises while the modeled pool is fixed, which direction does sodium change? Check: down, because the denominator grows. Transfer: explain why a patient with ascites does not automatically need salt replacement just because serum sodium is low. Total sodium and its concentration are different variables.
Read the kidney's response before naming a syndrome
Arginine vasopressin, also called ADH, is synthesized in the hypothalamus and released from the posterior pituitary. At collecting-duct V2 receptors it promotes apical aquaporin-2 insertion, allowing water reabsorption down the medullary gradient. Rising tonicity stimulates vasopressin and thirst. Falling tonicity normally suppresses vasopressin, permitting dilute urine. Low effective arterial volume, nausea and pain can override this osmotic suppression. Concentrated urine during hypotonicity is not automatically inappropriate. Vasopressin regulation [1]
Obtain serum and urine samples close together when feasible, without delaying emergency treatment. In hypotonic hyponatremia, urine osmolality at or below approximately 100 mOsm/kg indicates near-maximal dilution and directs attention toward water intake relative to solute excretion. Above 100, ask why dilution is limited: vasopressin effects, drugs and kidney dysfunction all matter. Urine osmolality is a physiological response, not a direct vasopressin measurement.
Urine sodium at or below approximately 30 mmol/L supports sodium conservation and low effective arterial volume in context. It does not by itself distinguish diarrhea from heart failure. A higher value may reflect SIAD, diuretics, adrenal disease, kidney injury or salt loss. Recent diuretic timing can uncouple urine sodium from arterial filling. Vomiting with bicarbonaturia may also raise urine sodium despite depletion; urine chloride and the broader acid-base context can help. Thresholds are clues, not diagnoses. Urine-first diagnostic algorithm and limitations [1]
Low solute intake limits the volume of water that can be excreted even when urine dilutes appropriately. If daily solute excretion is 150 mOsm and attainable urine osmolality is 50 mOsm/kg, approximate maximum urine volume is 150/50 = 3 L/day, treating 1 kg urine water as approximately 1 L. With 600 mOsm/day it is 12 L/day. These values are examples, not recommended intake limits; insensible losses and actual kidney function still matter. Low dietary protein reduces urea generation, while low salt reduces electrolyte osmoles. Nausea can superimpose antidiuresis, so low-solute hyponatremia need not always have urine osmolality below 100.
Restoring volume, replacing cortisol, stopping a thiazide or resolving nausea may abruptly remove a water-retaining signal. Urine can change from a small concentrated volume to a large dilute volume. This aquaresis can raise sodium rapidly even after saline has stopped. Repeat urine observations and sodium measurements are therefore more informative than assuming the initial urine pattern will persist. Monitoring spontaneous correction [2]
Predict: what happens after volume repletion changes urine osmolality from 600 to 80 mOsm/kg and urine output rises? Check: water excretion has increased and sodium may accelerate upward. Transfer: a stopped infusion is not a stopped correction.
Use independent evidence to separate look-alikes
SIAD, the syndrome of inappropriate antidiuresis, is a diagnosis of exclusion. Its usual pattern is hypotonic hyponatremia, urine osmolality above 100, urine sodium above 30 with adequate intake, and no evidence of effective volume depletion or edema. Exclude adrenal insufficiency, important thyroid dysfunction, major kidney impairment and recent diuretic effects. Low uric acid supports the pattern but is not specific. Pulmonary disease, CNS disease, SSRIs and carbamazepine are relevant triggers, not substitutes for the exclusions. SIAD diagnostic criteria [1]
Glucocorticoid deficiency reduces free-water excretion and can resemble SIAD closely. Primary adrenal insufficiency may additionally cause aldosterone deficiency, sodium loss, hyperkalemia and hypotension. Secondary adrenal insufficiency can retain aldosterone function and have normal potassium. In pituitary disease, a normal TSH does not exclude central hypothyroidism; assess free T4 with TSH and clinical context. Ordinary mild hypothyroidism rarely explains profound hyponatremia. A cortisol result must be interpreted with its timing, assay and clinical setting, not merely labeled normal.
After brain injury, high urine sodium occurs in both SIAD and renal salt wasting. Sustained negative sodium balance with measured weight loss, high urine output and worsening perfusion argues for salt wasting. Neither a brain lesion nor low uric acid distinguishes the two alone. Overdiagnosing salt wasting or assuming every CNS-associated low sodium is SIAD can reverse the appropriate fluid strategy.
Hypernatremia: is the kidney conserving water?
Hypernatremia with small volumes of concentrated urine favors intact conservation with inadequate intake or nonrenal losses. Hypernatremia with large volumes of dilute urine suggests a water diuresis. Central diabetes insipidus, now also termed AVP deficiency, impairs hormone supply; nephrogenic DI, or AVP resistance, impairs the renal response. Pituitary injury supports the former; lithium, hypercalcemia and hypokalemia support the latter. A marked rise in urine osmolality after supervised desmopressin supports deficient hormone action with preserved renal responsiveness. Partial forms, medullary washout and kidney disease complicate interpretation, so a modest response does not uniquely localize the defect. Renal water-loss interpretation [4]
Do not perform water deprivation in an unstable hypernatremic patient. Hypernatremia is already an osmotic stimulus, and further dehydration is hazardous. Stabilization and specialist-directed evaluation take priority. Known DI also becomes dangerous when a patient cannot obtain water or misses desmopressin, even if thirst was previously sufficient to maintain normal sodium. Inpatient DI safety [5]
Osmotic diuresis is not the same as water diuresis. Glucose, mannitol or abundant urinary urea can drive a large urine volume with substantial urine osmolality. For example, glycosuria with urine osmolality 600 is not the classic dilute-urine pattern of complete DI. Examine urine volume, solute excretion and urine sodium plus potassium, not osmolality alone. Urea may be relatively ineffective across cell membranes yet still contribute to urinary solute-driven water loss.
Predict: do identical urine sodium values establish identical causes? Check: no; a recent thiazide and documented negative fluid balance change the interpretation. Transfer: identify the independent history or serial finding that would argue against SIAD.
Separate symptom rescue from the correction ceiling
Hypotonicity can cause brain swelling, but the duration of hyponatremia and severity of symptoms are separate axes. A five-day drug history is not proof of an acute fall within 48 hours. Chronic hyponatremia permits cellular osmolyte loss that limits swelling but increases vulnerability to a rapid subsequent rise in tonicity. Osmotic demyelination can produce delayed dysarthria, dysphagia, paresis or movement abnormalities after initial improvement; lesions may be pontine or extrapontine and early MRI may be unrevealing. It is not simply visible myelin mechanically stripping off a shrinking neuron. Adaptation and ODS evidence [3]
Seizures, coma or other severe attributable hyponatremic neurologic symptoms require urgent monitored hypertonic saline without waiting to establish chronicity. Airway and seizure care proceed in parallel. The initial aim is a modest rise of about 4-6 mmol/L for symptom control, not rapid normalization. The 2022 Society for Endocrinology guidance recommends a 5 mmol/L initial rise and also addresses moderately severe attributable symptoms. Persistent symptoms require reassessment of alternative causes and further treatment under the clinical protocol, not an automatic drive toward a normal sodium. Emergency guidance [2]
This lesson uses the European/Society for Endocrinology limits: no more than 10 mmol/L in the first 24 hours and 8 mmol/L per 24 hours thereafter. For high ODS-risk patients, the US/Irish expert-panel approach summarized by Sterns and colleagues limits correction to 8 mmol/L in any 24 hours, with a lower working goal of 4-6 mmol/L/day. Very low starting sodium, especially at or below 105, malnutrition, alcohol use disorder, hypokalemia and advanced liver disease increase risk. These are upper limits, not targets or guarantees of safety. Unknown duration is managed cautiously. Chosen general limits [2]Risk-specific limits [3]
Worked trajectory: measured sodium is 112 at hour 0, 116 at hour 4 and 119 at hour 10 in a malnourished patient. The rise is already 7 mmol/L. A displayed high-risk 24-hour ceiling at 120 is a warning boundary, not permission to aim for 120 or a linear hourly allowance. If urine output is accelerating and urine becomes dilute, the immediate concern is additional aquaresis. Potassium repletion and all preceding fluid exposure count toward the observed rise.
Monitor sodium, urine output, urine composition as indicated and the patient's neurologic and volume state. Keep the measurement platform consistent when following a trajectory. A specialist may use desmopressin proactively to control anticipated aquaresis, reactively as correction accelerates, or as part of rescue after overshoot. A small 2024 randomized trial did not establish superiority of proactive over reactive treatment; the evidence does not support replacing monitoring with a universal clamp. If relowering is considered, the responsible senior clinician should direct desmopressin and controlled electrolyte-free water under a local protocol with frequent biochemical reassessment, especially in high-risk overshoot. Overcorrection management [2]DDAVP trial [7]
The SALSA trial randomized 178 patients to bolus or continuous hypertonic saline. Its primary result did not demonstrate superiority for overcorrection and was not proof of equivalence or identical risk. Research thresholds above 12 mmol/L at 24 hours or 18 at 48 hours were outcome definitions, not treatment targets. Few participants had seizures or major ODS risk factors, limiting generalization to those groups. Bolus guidance still requires measured responses and supervision; no dosing table here can replace that. SALSA primary report [6]
Predict: does improvement after a 4 mmol/L rise justify completing an 8 mmol/L rise? Check: no; symptom rescue and the safety ceiling serve different purposes. Transfer: explain how potassium and new dilute urine can raise sodium without additional hypertonic saline.
Reassess the cause as physiology changes
Cause-specific treatment follows, or accompanies, emergency stabilization. Depleted patients may need isotonic volume restoration and withdrawal of an offending thiazide; patients with SIAD often need restriction of water intake and treatment of the trigger. Isotonic saline can worsen SIAD when its sodium is excreted in sufficiently concentrated urine while water is retained, not because the kidney excretes dilute water. Vaptans are not emergency substitutes for hypertonic saline in severe symptomatic hyponatremia. Cause-specific care [1]Emergency exclusions [2]
For cirrhotic ascites, balance sodium restriction and selected diuretic therapy against renal perfusion, potassium and nutritional status. Fluid restriction is not a universal requirement for every patient with ascites; hyponatremia and volume context matter. The 2025 AGA update recommends water and sodium restriction with medication adjustment for asymptomatic hypervolemic hyponatremia, and volume-based inpatient management for severe or symptomatic disease. Do not restrict protein simply to treat ascites or hepatic encephalopathy. If aggressive diuresis causes actual intravascular depletion, reassess instead of reflexively escalating diuretics because edema remains. Ascites and nutrition [8]Current cirrhosis best-practice advice [9]
For hypernatremia with hypotension or shock, restore intravascular circulation with appropriate isotonic crystalloid before relying on calculated free-water replacement. Then replace water and address ongoing renal or nonrenal losses. The commonly used estimate water deficit = total body water × (sodium/140 − 1) estimates the positive water balance required to reach a reference sodium in a simplified system. With estimated total body water 35 L and sodium 154, the estimate is 3.5 L. It excludes subsequent losses and does not specify a safe infusion rate, route or endpoint for that patient. Total body water itself is uncertain and varies with body composition. Water deficit and resuscitation [4]
Hypernatremia correction depends on duration, cause, perfusion and observed response. Traditional caution for chronic or unknown-duration hypernatremia draws partly on pediatric data. Adult observational cohorts have not consistently shown the same neurologic harm with faster correction and have associated very slow correction with worse outcomes; confounding prevents treating those associations as a universal prescription. Do not transfer infant risk estimates directly to adults or deliberately reinduce adult hypernatremia simply because a conventional rate was exceeded. Reassess and involve the responsible specialist. Adult evidence limitations [4]
At each reassessment, join two kinds of evidence: the concentration and tonicity pattern, then the independent clinical context or measured response. Check what changed in the kidney, not only what changed on the infusion pump.
Predict: after desmopressin sharply reduces urine output, will the previous water replacement rate still match losses? Check: often not; the ongoing-loss component has changed. Transfer: explain why the initial deficit estimate must be revisited even if its arithmetic was correct.
Practice: connect the pattern to the next consequence
Choose the best answer using the specified timing, assay, volume findings and measured response, then compare the reasoning for every option.
Case 1
Show answer and explanations for case 1
A. Begin monitored hypertonic saline for a modest initial rise. (Best answer)
Effective osmolality is about 241 mOsm/kg because BUN is excluded. Profound hypotonicity with a seizure supports urgent monitored hypertonic saline for a modest initial rise even though chronicity is unknown.
B. Use water restriction as the initial sodium-directed treatment. (Why this does not fit)
Water restriction may help some stable causes of hypotonic hyponatremia, but it does not provide prompt control of severe attributable neurologic symptoms. The seizure changes the immediate priority.
C. Await repeat sodium after glucose normalization. (Why this does not fit)
Glucose is 90 mg/dL, so hyperglycemic translocation does not explain this sodium. The near-normal measured osmolality is largely accounted for by BUN, which does not remove the hypotonic emergency.
D. Confirm an indirect-ISE artifact before sodium-directed treatment. (Why this does not fit)
There is no major lipid or protein abnormality, and the low calculated tonicity remains after separating out urea. Waiting for an artifact explanation would delay treatment of a plausible severe hypotonic emergency.
Takeaway: Urea can conceal low tonicity in the total osmolality; severe attributable symptoms determine immediate rescue.
A. The initial low sodium was solely an indirect-ISE artifact. (Why this does not fit)
Glucose of 900 mg/dL supplies effective extracellular osmoles and produces real translocational lowering of sodium. No assay or plasma-solids evidence establishes an indirect-ISE artifact.
B. Initial glucose translocation resolved with balanced replacement; coefficient choice alone explains the final sodium. (Why this does not fit)
Five liters of glucosuric urine were not matched by replacement. Coefficient variation can affect the initial estimate, but the documented subsequent losses violate a fixed-balance explanation and must also be incorporated.
C. Glucose translocation coexisted with continuing osmotic water loss. (Best answer)
Initial hyperglycemia lowers sodium by shifting water extracellularly. Inadequately replaced glucosuric diuresis loses water during treatment; coefficient uncertainty also limits the initial estimate, so 138.8 was not a promised endpoint.
D. Complete central DI was the dominant cause of the observed polyuria. (Why this does not fit)
Urine osmolality of 650 with heavy glucosuria points to an osmotic diuresis rather than the markedly dilute urine expected in complete central DI. Urine volume alone does not diagnose DI.
Takeaway: Corrected sodium is an estimate under assumptions; ongoing losses can shift the eventual sodium away from it.
A. Isolated pseudohyponatremia; the sodium disturbance is analytical. (Why this does not fit)
Direct-ISE sodium remains low at 125 and measured osmolality is low. The indirect-method artifact explains part of the discrepancy, not the whole hypotonic disorder.
B. Pseudohyponatremia plus true hypotonic hyponatremia; investigate impaired dilution. (Best answer)
The paired assay gap in marked lipemia supports an indirect-ISE artifact. Direct sodium 125 and measured osmolality 259 establish residual hypotonicity, while concentrated urine warrants an impaired-dilution evaluation including the new SSRI.
C. Hyperglycemic translocation plus SIAD; investigate insulin deficiency. (Why this does not fit)
Glucose is 90 mg/dL, not a concentration that explains a major translocational sodium fall. The assay gap and residual hypotonicity instead require separating artifact from true low sodium.
D. True SIAD without an analytical component; disregard the direct-ISE result. (Why this does not fit)
A same-draw eight-point difference between indirect and direct ISE in severe lipemia supports an analytical component. SIAD remains a differential diagnosis after exclusions, but cannot erase the assay evidence.
Takeaway: An assay artifact and a genuine hypotonic disorder can coexist.
A. Continue symptom-rescue boluses while reassessing persistent hyponatremic encephalopathy. (Why this does not fit)
The seizure has stopped and mental status has returned to baseline after a four-point rise. Persistent hyponatremic encephalopathy is therefore not the supplied reason to continue rescue boluses.
B. Pause rescue boluses and keep the prior observation schedule because water excretion remains limited. (Why this does not fit)
Rising urine output with osmolality 85 signals aquaresis rather than persistent limited water excretion. Sodium may accelerate upward despite symptom resolution, so monitoring must adapt to the changed urine response.
C. Use isotonic saline to continue replacing presumed exercise salt losses. (Why this does not fit)
The stem documents water intake and a hypotonic neurologic emergency, not persisting circulatory depletion. After recovery, the measured dilute diuresis makes control of the sodium trajectory more important than unverified salt replacement.
D. Pause further rescue boluses and closely track the emerging water diuresis. (Best answer)
Neurologic recovery after a modest rise reduces the immediate need for additional rescue boluses. Increasing dilute urine output warns that spontaneous water loss may continue raising sodium and requires close monitoring and protocol-directed adjustment.
Takeaway: Initial clinical improvement does not end correction; the kidney may now be driving it.
A. SIAD is the leading explanation because urine sodium exceeds 30. (Why this does not fit)
Recent furosemide can raise urine sodium despite arterial underfilling, and the patient has overt congestive heart failure rather than clinical euvolemia. A single post-diuretic urine sodium cannot establish SIAD.
B. The kidney is conserving water in arterial underfilling, while the loop diuretic confounds sodium excretion. (Best answer)
Low effective arterial filling in heart failure can sustain vasopressin-mediated water retention despite edema. Furosemide independently increases sodium excretion, so the high urine sodium does not refute that underfilling.
C. Primary water overconsumption is the leading explanation because total body water is increased. (Why this does not fit)
Urine osmolality 540 is not the near-maximally dilute response expected in uncomplicated water overconsumption. Congestion and cool extremities provide a nonosmotic stimulus for antidiuresis.
D. Renal salt wasting is the leading explanation because urine sodium is high despite low serum sodium. (Why this does not fit)
The urine was sampled soon after intravenous furosemide. Drug-induced natriuresis plus congestive arterial underfilling explains this result without establishing a separate renal salt-wasting disorder.
Takeaway: Edema and arterial underfilling coexist; recent diuretics limit the specificity of urine sodium.
A. Persistent SIAD has intensified after feeding. (Why this does not fit)
Urine is dilute both before and after feeding, and its volume increases. That pattern does not support intensified SIAD as the cause of the rising sodium.
B. The kidney has developed complete AVP resistance because of the meal. (Why this does not fit)
Very low solute excretion limited water excretion before feeding. Providing solute can increase dilute urine volume without a new AVP-resistance disorder, so the temporal relationship to nutrition is mechanistically important.
C. More excreted solute permits greater water clearance, creating an overcorrection risk. (Best answer)
With dilute urine, low solute availability restricts excretable water volume. Nutrition increases the solute load and permits more water excretion; the observed diuresis and five-point rise demonstrate why refeeding requires sodium surveillance.
D. Restored arterial volume is the established cause of vasopressin suppression. (Why this does not fit)
The stem does not document initial volume depletion or a volume-restoring infusion, and urine was already dilute. The documented change is solute reintroduction followed by increased dilute urine volume.
Takeaway: Low solute limits water disposal; correcting the diet can itself accelerate sodium correction.
A. Extrarenal chloride depletion with bicarbonaturia; restore extracellular volume while monitoring sodium. (Best answer)
Vomiting-associated alkalosis can cause bicarbonate-linked urinary sodium loss while urine chloride stays low. Orthostasis and concentrated urine then support volume-driven antidiuresis, making monitored volume restoration more appropriate than treating the sodium result as SIAD.
B. SIAD with incidental vomiting; begin water restriction as the volume strategy. (Why this does not fit)
Orthostatic hypotension and dry mucosa indicate depletion, while low urine chloride with alkalosis fits vomiting-related chloride loss. Urine sodium 48 alone should not override those findings.
C. Active loop-diuretic natriuresis; intensify diuresis to improve water excretion. (Why this does not fit)
No diuretic is used, and urine chloride is low rather than showing ongoing diuretic-associated chloruresis. Intensifying diuresis would worsen the documented depletion.
D. Primary adrenal insufficiency with renal sodium loss; attribute the alkalosis to aldosterone deficiency. (Why this does not fit)
Marked alkalosis with vomiting and very low urine chloride fits extrarenal chloride loss. Aldosterone deficiency more typically impairs potassium and acid excretion, so it does not explain this supplied acid-base pattern as well.
Takeaway: Urine sodium can mislead during bicarbonaturia; interpret it with volume findings and urine chloride.
A. The five-day medication history establishes acute hyponatremia with little correction risk. (Why this does not fit)
Five days since drug initiation does not document a sodium fall within 48 hours. Hypokalemia and an uncertain sodium timeline still warrant conservative correction surveillance.
B. Residual thiazide salt loss is causing the sodium rise, so more saline should match every urine milliliter. (Why this does not fit)
The urine has become markedly dilute after improved perfusion and drug withdrawal. This points to water diuresis, so matching its full volume with saline would not address the changing electrolyte-free water loss appropriately.
C. The correction is determined by the potassium infusion alone because saline has been reduced. (Why this does not fit)
Urine output of 350 mL/hour with osmolality 75 indicates substantial water diuresis. Potassium replacement can also raise sodium, but it is not the only active driver.
D. Resolving antidiuresis has added aquaresis to replacement effects, increasing overshoot risk. (Best answer)
Withdrawal of the thiazide and relief of volume-driven antidiuresis can restore water excretion. The new high-volume dilute urine supplies direct evidence of aquaresis, while potassium replacement also contributes to correction.
Takeaway: After a reversible trigger resolves, reassess the kidney and count potassium as well as saline.
A. Primary aldosterone deficiency; expect persistent hyperkalemia to dominate correction. (Why this does not fit)
Pituitary disease with low cortisol and low ACTH supports a central defect, while potassium is normal. Aldosterone function may be preserved in secondary adrenal insufficiency, so hyperkalemia is not the expected defining problem here.
B. Secondary adrenal insufficiency mimicking SIAD; watch for emerging water diuresis. (Best answer)
Low cortisol with low ACTH in pituitary disease supports secondary adrenal insufficiency, which can impair water excretion despite normal potassium. Restoring glucocorticoid action can release the limitation on water excretion and produce aquaresis with a faster sodium rise.
C. SSRI-associated SIAD; glucocorticoids should not alter the sodium trajectory. (Why this does not fit)
Marked glucocorticoid deficiency is present and must be addressed before labeling the pattern SIAD. No SSRI exposure is given, and glucocorticoid replacement can materially change renal water handling.
D. Secondary adrenal insufficiency mimicking SIAD; expect the initial water-retaining pattern to persist unchanged. (Why this does not fit)
Glucocorticoid replacement restores a factor needed for normal free-water excretion. Even with the correct endocrine diagnosis, assuming continued concentrated low-volume urine could miss newly emerging aquaresis and accelerated sodium correction.
Takeaway: Normal potassium does not exclude secondary adrenal insufficiency; cortisol replacement can unmask rapid water excretion.
A. The saline corrected a hidden volume deficit and triggered dilute water excretion. (Why this does not fit)
Urine remains concentrated and its sodium plus potassium concentration is high. A dilute aquaresis would tend to raise, rather than explain the observed fall in, serum sodium.
B. The saline caused an indirect-ISE artifact by increasing plasma solids. (Why this does not fit)
Isotonic saline does not create the marked lipid or protein excess required for this assay artifact. The hypotonic state and concentrated electrolyte-rich urine instead support a physiological water-balance explanation.
C. Persistent antidiuresis allowed infused salt to be excreted with relatively less water retained in urine. (Best answer)
Urine sodium plus potassium of 190 exceeds the 154 mmol/L sodium concentration of isotonic saline. In persistent antidiuresis, the infused electrolyte can leave in a smaller water volume, leaving relatively more water in the body and lowering sodium.
D. Glucose in the saline shifted water out of cells and diluted extracellular sodium. (Why this does not fit)
The administered fluid was isotonic saline, not a glucose-containing infusion, and no hyperglycemia is reported. The observed urine electrolyte concentration provides a better explanation for the fall.
Takeaway: In SIAD, saline may leave behind water when its electrolyte is excreted in concentrated urine.
A. CNS-associated renal salt wasting; replace measured deficits while reassessing. (Best answer)
Documented negative sodium balance, weight loss and worsening perfusion show depletion despite renal sodium loss. That serial evidence favors salt wasting and monitored replacement over reflexive water restriction for CNS-associated SIAD.
B. CNS-associated SIAD; restrict water because the urine sodium is high. (Why this does not fit)
Sustained negative sodium balance with weight loss and orthostatic hypotension indicates actual depletion. High urine sodium and a CNS lesion occur in both patterns and do not outweigh these serial findings.
C. Central DI; replace urine water and use desmopressin for the dominant defect. (Why this does not fit)
Complete central DI typically produces hypotonic polyuria with a tendency toward hypernatremia when water intake fails. Here urine is concentrated, serum is hypotonic and measured renal sodium loss accompanies depletion.
D. Hypervolemic hyponatremia from fluid loading; intensify diuresis. (Why this does not fit)
Weight is falling, sodium balance is negative and perfusion is worsening. These measured trends support depletion rather than a hypervolemic state needing more diuresis.
Takeaway: Following CNS injury, urine sodium alone cannot distinguish SIAD from salt wasting; serial balance and perfusion matter.
A. A fixed SIAD process is established by the first urine sample. (Why this does not fit)
Urine osmolality falls to 65 when nausea resolves, showing that strong antidiuresis is no longer present. The initial concentrated sample therefore cannot establish a persistent fixed SIAD process.
B. The initial low sodium was analytical, and the later diuresis is unrelated. (Why this does not fit)
Measured osmolality is low and the history documents large water intake. The subsequent dilute diuresis after nausea resolves directly fits changing water handling, without any assay-artifact evidence.
C. Persistent low solute intake is proven by the dilute second sample. (Why this does not fit)
No low dietary solute intake or low daily solute excretion is documented. Dilute urine shows reduced antidiuresis, but does not by itself prove that a solute ceiling caused the original hyponatremia.
D. Water loading occurred during nausea-driven antidiuresis; its resolution now permits rapid aquaresis. (Best answer)
Large water intake occurred while nausea could sustain nonosmotic vasopressin release. Resolution of nausea followed by high-volume urine at osmolality 65 shows release of that water-retaining state and a risk of spontaneous sodium rise.
Takeaway: A urine snapshot must be interpreted at the time it was obtained; reversible nausea can change the whole trajectory.
A. AVP deficiency is favored; maintain the earlier water rate because the initial deficit fixes replacement needs. (Why this does not fit)
AVP deficiency fits the strong desmopressin response, but output has fallen from 500 to 70 mL/hour. The original deficit does not include a permanent obligation to replace losses at their previous rate, so ongoing needs must be reassessed.
B. AVP deficiency is favored; reassess replacement because ongoing water losses have fallen. (Best answer)
A strong concentrating response after pituitary surgery supports AVP deficiency rather than major renal resistance. The fall in output reduces ongoing replacement needs, so the prior fluid rate must be reassessed rather than carried forward mechanically.
C. Glucose-driven osmotic diuresis is favored; continue insulin-directed correction. (Why this does not fit)
There is no glucosuria, the initial urine is extremely dilute and desmopressin produces a large concentrating response. Those findings favor a hormone-responsive water diuresis rather than glucose-driven solute excretion.
D. Extrarenal water loss is favored; the renal response need not change the replacement estimate. (Why this does not fit)
Hypernatremia with very high output at urine osmolality 95 shows failure to conserve water. The subsequent reduction in that renal loss directly changes the ongoing component of replacement.
Takeaway: A hormone response can localize a defect and simultaneously change the replacement requirement.
A. Central AVP deficiency was compensated by drinking until water access failed. (Why this does not fit)
Little concentrating response to supervised desmopressin is less consistent with complete hormone deficiency and preserved renal responsiveness. The water-access history fits compensation, but lithium exposure and the renal response favor AVP resistance.
B. Primary polydipsia caused both the previous polyuria and current hypernatremia. (Why this does not fit)
With sodium 158, intact kidneys should substantially concentrate urine in response to hypertonicity. Continued dilute urine despite loss of access to water is not explained well by uncomplicated primary polydipsia.
C. Lithium-associated AVP resistance was compensated by drinking until water access failed. (Best answer)
Lithium exposure and little desmopressin response support AVP resistance with chronic renal water loss. Previously, drinking could match that loss; inability to obtain water removed the compensation and allowed hypernatremia.
D. Lithium-associated AVP resistance began during this illness; renal conservation had prevented earlier water loss. (Why this does not fit)
Long-standing polyuria with frequent compensatory drinking preceded the illness. Prior normal sodium therefore does not show preserved renal water conservation; the new failure of water access explains why the chronic loss is now uncompensated.
Takeaway: DI may remain normonatremic while thirst and water access compensate; losing access changes the risk.
A. Restore intravascular perfusion with isotonic crystalloid, then reassess water deficit and continuing losses. (Best answer)
The concentrated low-volume urine is compatible with conservation during nonrenal loss, while hypotension and poor perfusion indicate shock. Isotonic resuscitation addresses circulation first; the water deficit and continuing diarrhea must then be managed with reassessment.
B. Begin deficit-based electrolyte-free water alone as the resuscitation fluid. (Why this does not fit)
Severe hypotension and delayed refill require effective intravascular volume restoration. A water-deficit calculation describes another component of the disorder and should not displace initial isotonic resuscitation in shock.
C. Give desmopressin first to stop the dominant renal water loss. (Why this does not fit)
Low urine volume with osmolality 890 shows strong renal concentration. The supplied diarrhea and poor intake explain loss better than DI, so desmopressin is not the initial remedy for the shock.
D. Perform water deprivation before selecting the replacement fluid. (Why this does not fit)
The patient is already hypernatremic and in shock, with concentrated urine providing evidence of renal conservation. Further deprivation would worsen depletion and delay needed resuscitation.
Takeaway: Hypernatremia does not cancel the need to restore perfusion first in shock.
A. Complete central DI, because every high-volume urine is a water diuresis. (Why this does not fit)
The urine is solute-rich at osmolality 610 and contains abundant glucose. Complete central DI usually produces much more dilute urine, so volume alone should not determine the diagnosis.
B. Appropriate maximal water conservation, because urine osmolality exceeds plasma osmolality. (Why this does not fit)
Six liters per day is a major loss, and most measured urine osmoles are not sodium or potassium. Glucose can raise urine osmolality while the low electrolyte concentration permits substantial electrolyte-free water loss.
C. Renal sodium loading, because a high urine osmolality demonstrates high sodium excretion. (Why this does not fit)
Urine sodium plus potassium is only 35 mmol/L despite osmolality 610. Glucose supplies substantial osmoles, so high total urine osmolality does not establish a high sodium concentration or a sodium-loading mechanism.
D. Glucose-driven osmotic diuresis with substantial electrolyte-free water loss. (Best answer)
Glucosuria with high-volume solute-rich urine identifies osmotic diuresis. The low urine sodium plus potassium relative to plasma sodium shows that this loss can remove proportionally more water than electrolytes and aggravate hypernatremia.
Takeaway: A urine can be hyperosmolar yet carry electrolyte-free water out of the body when glucose supplies the osmoles.
A. Withhold hypertonic saline because the hyponatremia is chronic. (Why this does not fit)
A seizure plausibly attributable to profound hypotonicity requires urgent monitored rescue even in chronic hyponatremia. Chronicity changes the subsequent correction limits, not the need to treat this emergency.
B. Use monitored hypertonic saline for an initial 4-6 mmol/L rise, then tightly constrain total correction. (Best answer)
Severe attributable symptoms support an initial modest rise for brain-swelling relief. Documented chronicity plus malnutrition, alcohol use and hypokalemia heighten ODS risk, supporting a high-risk limit of 8 mmol/L in any 24 hours rather than normalization.
C. Use monitored hypertonic saline for an initial 4-6 mmol/L rise, then apply the general 10 mmol/L first-day ceiling. (Why this does not fit)
The initial rescue objective is appropriate, but malnutrition, alcohol use and hypokalemia confer high ODS risk. This lesson applies the stricter 8 mmol/L limit in any 24 hours to such patients rather than the general first-day 10 mmol/L ceiling.
D. Replace potassium first and defer sodium-directed rescue until it is normal. (Why this does not fit)
Potassium replacement is necessary and contributes to the sodium rise, but it does not replace urgent monitored treatment of a hyponatremic seizure. Both interventions require coordinated tracking of total correction.
Takeaway: Chronicity and ODS risk constrain the course; they do not justify withholding emergency symptom rescue.
A. Continue unchanged because no hypertonic saline is running. (Why this does not fit)
The high-volume urine at osmolality 60 indicates aquaresis. That ongoing water loss can accelerate sodium correction independently of the saline pump.
B. Resume hypertonic saline until sodium reaches the displayed 120 ceiling. (Why this does not fit)
The seven-point rise already approaches the high-risk daily limit, while aquaresis may add more. The ceiling is a warning boundary, not an instruction to deliver the remaining increment.
C. Escalate monitoring and obtain protocol-directed expert control of aquaresis, including consideration of desmopressin. (Best answer)
Advanced liver disease and poor intake increase ODS risk, and sodium has already risen seven points. The new brisk dilute diuresis predicts further rise, supporting prompt senior-directed trajectory control rather than waiting for the limit to be exceeded.
D. Wait until the next routine daily sample before considering relowering. (Why this does not fit)
A seven-point rise in ten hours with rapidly increasing dilute output can change substantially before the next day. High-risk correction requires frequent reassessment and timely protocol-directed prevention or rescue.
Takeaway: Risk assessment uses the measured trajectory and the kidney response, not only the current infusion order.
A. Potassium repletion can contribute to the sodium rise, which still counts toward the daily limit. (Best answer)
Exchangeable potassium contributes to the body cation-to-water relationship that influences serum sodium. Repletion can therefore raise sodium; the observed five-point rise counts toward correction limits even though sodium infusion is paused and urine remains concentrated.
B. A new water diuresis is the dominant demonstrated mechanism. (Why this does not fit)
Urine remains concentrated at 520, output is low and recorded balance is approximately even. Those findings do not demonstrate the brisk dilute water loss expected in aquaresis.
C. The sodium rise can be excluded from correction limits because potassium was the administered cation. (Why this does not fit)
The brain experiences the observed change in extracellular tonicity, not the name of the administered electrolyte. A sodium rise during potassium treatment therefore remains part of total correction.
D. Persistent SIAD prevents potassium replacement from affecting serum sodium. (Why this does not fit)
Serum sodium is related to exchangeable sodium plus potassium relative to body water. Persistent concentrated urine does not make potassium replacement irrelevant to that relationship, and the measured sodium rise still requires accounting.
Takeaway: Count the measured rise from every mechanism, including potassium replacement.
A. Recurrent hypotonic cerebral edema is established by the new symptoms. (Why this does not fit)
Sodium is stable rather than newly falling, and neurologic decline follows a delay after a large correction and initial improvement. That sequence fits a delayed correction-related injury better than recurrent acute hypotonic swelling.
B. ODS is excluded because the first MRI is negative. (Why this does not fit)
MRI abnormalities can lag clinical ODS. A negative early study does not exclude it when delayed bulbar and motor findings follow a large correction in a high-risk patient.
C. The stable current sodium excludes any correction-related neurologic injury. (Why this does not fit)
The first-day rise was 15 mmol/L from a very low chronic baseline. Delayed injury can emerge after sodium has stabilized, so the current value does not erase the preceding exposure.
D. Osmotic demyelination remains a leading concern despite the early MRI. (Best answer)
A large first-day rise in a chronically hyponatremic undernourished patient is followed by initial improvement and delayed bulbar and symmetric motor deficits. This biphasic sequence supports ODS, whose imaging findings may lag symptoms.
Takeaway: ODS can be delayed and initially MRI-negative; current sodium alone cannot reconstruct correction risk.
A. The handoff is valid because each midnight-to-midnight total is below 8. (Why this does not fit)
From hour 12 to hour 36, sodium rises from 112 to 124, a 12 mmol/L rise within 24 hours. The high-risk rule applies to any 24-hour interval rather than resetting at midnight.
B. The rolling 24-hour rise is excessive and warrants prompt senior-directed review for control or relowering. (Best answer)
The hour-12 to hour-36 rise is 12 mmol/L in 24 hours. Malnutrition independently places the patient in a high-risk group, so symptom resolution does not remove the need for protocol-directed assessment of overcorrection.
C. Only the hour-0 to hour-24 rise determines risk throughout the admission. (Why this does not fit)
The patient continues to rise after hour 24, including a 12-point rolling 24-hour interval. Subsequent correction remains biologically relevant and must be tracked rather than excluded after the first-day calculation.
D. Resolved symptoms make additional correction acceptable until sodium is normal. (Why this does not fit)
Symptom rescue and ODS prevention are different objectives. Clinical improvement does not cancel the stricter high-risk correction limit or justify ignoring the later steep rise.
Takeaway: For a rule stated as any 24 hours, inspect rolling intervals rather than calendar-day labels.
A. Residual edema proves adequate intravascular filling, so escalate diuretics. (Why this does not fit)
Rapid weight loss, orthostasis and rising creatinine after diuresis and stool losses suggest superimposed depletion. Residual interstitial fluid does not prove adequate intravascular filling.
B. The low sodium proves a total-body sodium deficit that should be corrected without volume reassessment. (Why this does not fit)
Serum sodium is a concentration, not a total-body sodium inventory. Cirrhosis can involve excess total sodium, while the new perfusion changes require assessment of superimposed depletion rather than inference from sodium alone.
C. Reassess for superimposed intravascular depletion and modify losses and diuretics despite residual edema. (Best answer)
Intensified diuresis and stool losses precede weight loss, orthostasis and kidney dysfunction. Those independent trends support reassessing intravascular depletion and modifying contributors, rather than automatically intensifying ascites therapy because edema persists.
D. Restrict protein to reduce ascites and continue the current diuretic regimen. (Why this does not fit)
Protein restriction does not correct the documented perfusion problem and risks worsening malnutrition. Cirrhosis guidance supports adequate protein while adjusting diuretics and other losses to clinical and renal tolerance.
Takeaway: Edema does not protect a patient from becoming intravascularly depleted during treatment.
A. About 3.5 L initially; new nonrenal loss makes that static estimate incomplete. (Best answer)
The stated calculation is 35 × (154/140 − 1) = 3.5 L. New stool loss adds an ongoing requirement outside that starting estimate, while concentrated low-volume urine supports conservation rather than a new dominant renal water diuresis.
B. About 7 L initially; new nonrenal loss makes that static estimate incomplete. (Why this does not fit)
New stool losses do make the estimate incomplete, but 35 × (154/140 − 1) is 3.5 L, not 7 L. A 7 L answer would require a different body-water assumption or additional quantified deficit.
C. About 3.5 L initially; newly developed complete central DI explains the later response. (Why this does not fit)
The 3.5 L arithmetic is correct, but urine remains concentrated and low-volume. That pattern does not support complete central DI; the independently documented new stool loss better explains the shortfall.
D. About 7 L initially; newly developed complete central DI explains the later response. (Why this does not fit)
The stated TBW and sodium yield 3.5 L rather than 7 L, and concentrated low-volume urine argues against complete central DI. Both the calculation and the proposed later renal mechanism conflict with the supplied data.
Takeaway: Correct arithmetic does not make a static water-deficit estimate a complete fluid plan.
A. Hypernatremia from sodium gain with intravascular depletion; prioritize isotonic resuscitation. (Why this does not fit)
The patient has gained weight, developed edema and remains hemodynamically stable without major losses. Sodium gain is documented, but the independent volume findings support expansion rather than an initial isotonic shock-resuscitation strategy.
B. Dilutional hyponatremia from expanded extracellular volume. (Why this does not fit)
Measured sodium rose to 154, so water gain was insufficient relative to the added effective solute. Extracellular expansion can coexist with hypernatremia when sodium gain predominates.
C. A pure renal concentrating defect masked by edema. (Why this does not fit)
A large hypertonic sodium load is documented, while major renal losses are not. Invoking a pure concentrating defect ignores the measured positive balance and direct solute exposure.
D. Hypervolemic hypernatremia from sodium gain; assess both excess sodium and relative water deficit. (Best answer)
The hypertonic load explains increased sodium relative to water. Weight gain and edema show expanded extracellular volume, so subsequent planning must account for sodium excess as well as water relative to solute rather than blindly applying a water-only replacement estimate.
Takeaway: Hypernatremia can reflect sodium gain; volume and intake history determine whether a pure deficit model fits.
A. Treat the ten-point difference as a verified physiological correction. (Why this does not fit)
It compares an indirect-ISE baseline affected by marked lipemia with a direct-ISE follow-up. The paired baseline direct result permits a like-for-like comparison and prevents treating an assay gap as a physiological rise.
B. Use the two-point direct-to-direct rise while continuing evaluation of genuine baseline hypotonicity. (Best answer)
Direct sodium rose from 126 to 128, a two-point change. Measured osmolality 262 and direct sodium 126 show genuine hypotonicity requiring continued assessment, even though the baseline assay gap supports an additional indirect-method artifact.
C. Discard both direct-ISE values because the indirect result is the standard serum value. (Why this does not fit)
Direct ISE avoids the dilution-related plasma-water-fraction artifact associated with marked lipemia. Discarding the paired direct results would preserve the known source of misleading correction accounting.
D. Classify the whole episode as isolated pseudohyponatremia and stop sodium surveillance. (Why this does not fit)
Measured osmolality is low and direct-ISE sodium is 126. These findings show a true hypotonic component in addition to the indirect-method artifact, so continued assessment remains necessary.
Takeaway: Compare like with like when tracking correction; an assay gap is not a treatment-induced sodium rise.
